The present invention is related to a device and method that provides full wrist fusion.
Generally, wrist fusion apparatuses are used in patients with post-traumatic or degenerative wrist arthritis, conditions involving significant loss of bone substance, or failed total and partial wrist arthrodesis. Wrist arthrodesis can also be utilized in patients with complex fractures of the wrist, or with rheumatoid arthritis.
It is common for some types of wrist fusion apparatuses to extend from the radius to a metacarpal, particularly the third metacarpal, of the hand. Wrist fusion apparatuses of this variety are typically fastened both to the radius and to the third metacarpal by bone screws, and wrist fusion apparatuses of this type also therefore overlie the carpus area and the bones of the carpus area, which are positioned between the radius and the metacarpal bones. As known to those of skill in the art, bone grafts can be packed between the radius, the carpus area bones, and the metacarpals after such a wrist fusion plate is in place, and the bone grafts typically will bond with the adjacent bones in order to create a fused bone mass at the wrist joint.
Because wrist fusion plate apparatuses and methods require attachment of a portion of the wrist fusion plate to one or more of the metacarpals of the hand, they can cause undesirable disadvantages, such as the development of extensor tendinitis at the prominent distal end of the plate (which may necessitate removal of the plate and a second surgical procedure).
The present disclosure generally relates to a device for application to a wrist joint for use in an orthopaedic procedure, and, more particularly, to a wrist fusion plate for fusing a wrist joint. The wrist fusion device of the invention may be applicable for correction of bone deformation due to arthritis, rheumatoid arthritis, inflammatory diseases such as rheumatic fever or tuberculosis, genetic disorders of the bone, or for setting a wrist fracture.
Aspects of the present device include a first section, most preferably in the form of a metal bar or plate, that is positioned over the top of the forearm and extends past the wrist to fuse the wrist to the forearm and preferably fuse the bones in the wrist. The device further includes a second section integrally formed with or connected to the first section. The second section preferably narrows to the shape of a spike or awl. In use, an appropriate incision is made, such as lengthwise along the hand, wrist and forearm. The wrist is bent and the second section is pushed under the skin of the hand until it is properly seated inside of the cannula of the third metacarpal bone (the material in the cannula may be loosened first, using any suitable technique or device). One the second section is in place, the wrist is preferably straightened and the first section is placed under the skin across the wrist and onto the top the forearm. The plate is then secured using any suitable technique, such as bone screws that pass through apertures on the plate and into one or more of the radius and/or carpal bones.
A device according to the invention may include an anti-rotational third section. The third section may be connected to or integrally formed with the rest of the device. One aspect of the anti-rotational device could be a plate that extends upward and outward, above the second section, and is secured by one or more fasteners to the top of the third metacarpal bone.
The one or more fasteners may also be received in the part of the second section that is positioned in the cannula of the third metacarpal to provide additional anti-rotational stability. Further, an anti-rotational structure may be provided that includes no third section, but merely one or more fasteners that pass through, and are connected to, the top of the third metacarpal bone and that are also received in the second section.
Turning now to the Figures, where the purpose is to describe preferred embodiments according to the invention and not limit same,
First section 20 is configured to fit under the skin of the forearm and wrist and connect to the radius bone and one or more carpal bones in the forearm and/or wrist in order to secure section 20.
First section 20 is preferably an elongated plate having a length of 45 mm-75 mm, and most preferably about 60 mm, a thickness of between 3 and 4 mm, and most preferably about 3.5 mm, and a width of 9-15 mm, and most preferably about 11 mm. First section 20 includes a first end 22, apertures 24, a top surface 26 and a bottom surface 28. Apertures 24 pass from top surface 26 through bottom surface 28 to enable bone screws (which means any device suitable to connect first section 20 to one or more bones in the forearm and/or wrist) 30, which are shown in
As shown in
First section 20 also preferably includes a bended portion, or bend, 32. Bend 32 is at a preferred angle of about 10°-20°, is positioned at the wrist and marks the transition from the portion of device 10 on the forearm to the portion on the top of the hand. In a preferred embodiment, the bend has a drop D of between 0.5 and 1.5, and most preferably about 1.0 cm, and a length of between 15 and 25 mm, and most preferably 20 mm. Alternatively, first section 20 may be straight.
There are preferably three or more apertures 24 (or 24A) on first section 20, and most preferably five with one located at about the center of the wrist.
Second section 50 is either connected to or (most preferably) integrally formed with first section 20. As shown, after or during the bend 32, device 10 narrows and conforms in shape to form second end 50, although it could conform in shape to form second end 50 at any suitable location, whether or not device 10 has a bend 32. In this embodiment, second end 50 has an end 52 and a cylindrical body 54. Depending on the overall shape of device 10, second section 50 may extend upward at a 10°-20° angle, and most preferably about 15°, from the position at which it meets first portion 20, or extend straight from that position, or extend at any suitable angle. As shown, second section 50 is between 30 and 50 mm, and most preferably about 40 mm in length. The portion that extends into the cannula of the third metacarpal is preferably 3-4 mm, and most preferably about 3.5 mm in diameter. Second section 50 may include either longitudinal ribs, latitudinal ribs, or both.
An optional third section 100 is an anti-rotational section that helps prevent device 10 from rotating. Preferably third section 100 is a separate piece attached to device 10 immediately after bend 32 or at any suitable location. Third section 100 extends upward and outward so that it extends generally above second section 50. It has an attachment portion 102 with one or more screw holes 104 (shown in
Optionally, second portion 50 has one or more receiving apertures 60 (shown in
In use, an appropriate incision is made preferably lengthwise along the hand, across the wrist and along part of the forearm so that device 10 may be received under the skin. The wrist is then flexed downward and second section 50 is pressed into the cannula of the third metacarpal bone. If the third section 100 is used, and if not integrally formed with device 10, it will preferably have already been connected to device 10 prior to the placement of second section 50 into the third metacarpal bone. Third section 100 (if used) is secured to the top of the third metacarpal bone by positing screws 106 through the screw holes and securing them to the top of the third metacarpal bone, as previously described. Alternatively, screws 106 may also be received into receiving apertures formed in second portion 50 that are positioned inside the third metacarpal bone. Or, no third section 100 is used and one or more screws are positioned through the top of the third metacarpal bone and into one or more receiving apertures of the second portion 50 to help prevent rotation.
Then wrist is straightened and section 20 is positioned o the forearm and wrist. Screws 30 are then placed through the apertures 24 into the radius and/or one or more carpal bones to secure device 10.
Some specific examples of the invention are as follows:
Having thus described some embodiments of the invention, other variations and embodiments that do not depart from the spirit of the invention will become apparent to those skilled in the art. The scope of the present invention is thus not limited to any particular embodiment, but is instead set forth in the appended claims and the legal equivalents thereof. Unless expressly stated in the written description or claims, the steps of any method recited in the claims may be performed in any order capable of yielding the desired result.
Number | Name | Date | Kind |
---|---|---|---|
1741279 | Bowman | Dec 1929 | A |
2037586 | Olson | Apr 1936 | A |
2210455 | Hosking | Aug 1940 | A |
2217951 | Hosking | Oct 1940 | A |
2229892 | Hosking | Jan 1941 | A |
2242003 | Lorenzo | May 1941 | A |
3078900 | Walker | Feb 1963 | A |
3275055 | Gutshall | Sep 1966 | A |
3397699 | Kohl | Aug 1968 | A |
3717146 | Halloran | Feb 1973 | A |
4016874 | Maffei | Apr 1977 | A |
4175555 | Herbert | Nov 1979 | A |
4350465 | Lovisek | Sep 1982 | A |
4380414 | Capuano | Apr 1983 | A |
4463753 | Gustilo | Aug 1984 | A |
4471777 | McCorkle | Sep 1984 | A |
4584722 | Levy et al. | Apr 1986 | A |
4608965 | Anspach | Sep 1986 | A |
4653487 | Maale | Mar 1987 | A |
4764066 | Terrell | Aug 1988 | A |
4781191 | Thompson | Nov 1988 | A |
4812095 | Piacenti | Mar 1989 | A |
4820235 | Weber et al. | Apr 1989 | A |
4842463 | Landt | Jun 1989 | A |
4901717 | Moore et al. | Feb 1990 | A |
4909789 | Taguchi et al. | Mar 1990 | A |
5061283 | Silvestrini | Oct 1991 | A |
5234299 | Giannuzzi | Aug 1993 | A |
5312255 | Bauer | May 1994 | A |
5345927 | Bonutti | Sep 1994 | A |
5443466 | Shah | Aug 1995 | A |
5522846 | Bonutti | Jun 1996 | A |
5645545 | Bryant | Jul 1997 | A |
5667510 | Combs | Sep 1997 | A |
5690633 | Taylor et al. | Nov 1997 | A |
5840078 | Yerys | Nov 1998 | A |
5853413 | Carter et al. | Dec 1998 | A |
6187007 | Frigg | Feb 2001 | B1 |
6221006 | Dubrul et al. | Apr 2001 | B1 |
6231319 | Lida et al. | May 2001 | B1 |
6231413 | Tsukamoto | May 2001 | B1 |
6306140 | Siddiqui | Oct 2001 | B1 |
6394725 | Dicke | May 2002 | B1 |
6475242 | Bramlet | Nov 2002 | B1 |
6517541 | Sesic | Feb 2003 | B1 |
6592623 | Bowlin et al. | Jul 2003 | B1 |
6607530 | Carl et al. | Aug 2003 | B1 |
6808526 | Magerl et al. | Oct 2004 | B1 |
7037309 | Well et al. | May 2006 | B2 |
7041106 | Carver et al. | May 2006 | B1 |
7063491 | French | Jun 2006 | B2 |
7334976 | Dicke | Feb 2008 | B2 |
7465135 | Fritsch | Dec 2008 | B2 |
7507242 | Triplett et al. | Mar 2009 | B2 |
7604659 | Lee | Oct 2009 | B2 |
7708738 | Fourcault et al. | May 2010 | B2 |
7766942 | Patterson | Aug 2010 | B2 |
7988724 | Salahieh et al. | Aug 2011 | B2 |
8011866 | Harris | Sep 2011 | B2 |
8157803 | Zirkle, Jr | Apr 2012 | B1 |
8348575 | Walther | Jan 2013 | B2 |
8398687 | Vasta et al. | Mar 2013 | B2 |
8414648 | Reiley | Apr 2013 | B2 |
8419776 | Prandi et al. | Apr 2013 | B2 |
8518042 | Winsow et al. | Aug 2013 | B2 |
8568462 | Sixto et al. | Oct 2013 | B2 |
8597337 | Champagne | Dec 2013 | B2 |
8608783 | Graham et al. | Dec 2013 | B2 |
8814918 | Orbay et al. | Aug 2014 | B2 |
8852253 | Mafi | Oct 2014 | B2 |
8864804 | Champagne et al. | Oct 2014 | B2 |
8888429 | Pamer | Nov 2014 | B2 |
8906075 | Conley et al. | Dec 2014 | B2 |
9017404 | Champagne et al. | Apr 2015 | B2 |
9046120 | Phua | Jun 2015 | B2 |
9086088 | Walther | Jul 2015 | B2 |
9175715 | Babej | Nov 2015 | B2 |
9265600 | Niese | Feb 2016 | B2 |
9480515 | Champagne | Nov 2016 | B2 |
9539084 | Champagne | Jan 2017 | B2 |
10098680 | Champagne | Oct 2018 | B2 |
10441330 | Champagne et al. | Oct 2019 | B2 |
20010049529 | Cachia et al. | Dec 2001 | A1 |
20020045897 | Dixon | Apr 2002 | A1 |
20020055747 | Cano et al. | May 2002 | A1 |
20020055749 | Esnouf et al. | May 2002 | A1 |
20020143337 | Orbay | Oct 2002 | A1 |
20020198527 | Muckter | Dec 2002 | A1 |
20030014077 | Leung | Jan 2003 | A1 |
20030083661 | Orbay | May 2003 | A1 |
20030130735 | Rogalski | Jul 2003 | A1 |
20040193217 | Lubbers | Sep 2004 | A1 |
20040210227 | Trail et al. | Oct 2004 | A1 |
20040260288 | Means | Dec 2004 | A1 |
20050075642 | Felt et al. | Apr 2005 | A1 |
20050085824 | Castaneda | Apr 2005 | A1 |
20050107791 | Manderson | May 2005 | A1 |
20050143735 | Kyle | Jun 2005 | A1 |
20060089647 | Culbert | Apr 2006 | A1 |
20060129153 | Klaue et al. | Jun 2006 | A1 |
20060149249 | Mathoulin et al. | Jul 2006 | A1 |
20060165506 | Panasik | Jul 2006 | A1 |
20060189987 | Orbay et al. | Aug 2006 | A1 |
20060195099 | Bottlang | Aug 2006 | A1 |
20060271061 | Beyar | Nov 2006 | A1 |
20060276790 | Dawson | Dec 2006 | A1 |
20070027547 | Rydell et al. | Feb 2007 | A1 |
20070135816 | Kropf et al. | Jun 2007 | A1 |
20070282342 | Niederberger et al. | Dec 2007 | A1 |
20070299449 | Allinniemi et al. | Dec 2007 | A1 |
20080183220 | Glazer | Jul 2008 | A1 |
20080219801 | Toenjes | Sep 2008 | A1 |
20080249547 | Dunn | Oct 2008 | A1 |
20080249574 | McCombs et al. | Oct 2008 | A1 |
20090062868 | Casutt | Mar 2009 | A1 |
20090299369 | Orbay et al. | Dec 2009 | A1 |
20100106254 | Delsignore | Apr 2010 | A1 |
20100121136 | Champagne | May 2010 | A1 |
20100130978 | Orbay | May 2010 | A1 |
20100211115 | Tyber et al. | Aug 2010 | A1 |
20100278614 | Bickford | Nov 2010 | A1 |
20100312286 | Dell'Oca | Dec 2010 | A1 |
20100324556 | Tyber et al. | Dec 2010 | A1 |
20110009865 | Orfaly | Jan 2011 | A1 |
20110130794 | Vaidya | Jun 2011 | A1 |
20120083847 | Heubner et al. | Apr 2012 | A1 |
20120136398 | Mobasser | May 2012 | A1 |
20120191140 | Bonutti | Jul 2012 | A1 |
20120209270 | Segina | Aug 2012 | A1 |
20120221104 | Altman et al. | Aug 2012 | A1 |
20120253464 | Hwang et al. | Oct 2012 | A1 |
20120253465 | Missos | Oct 2012 | A1 |
20130012987 | Klein et al. | Jan 2013 | A1 |
20130053961 | Darwin et al. | Feb 2013 | A1 |
20130060333 | Gonzalez | Mar 2013 | A1 |
20130131699 | Jiang et al. | May 2013 | A1 |
20130138123 | Stone et al. | May 2013 | A1 |
20130165979 | Greenberg | Jun 2013 | A1 |
20130190872 | Makower et al. | Jul 2013 | A1 |
20130197592 | Mafi | Aug 2013 | A1 |
20130245626 | Lavi et al. | Sep 2013 | A1 |
20130245700 | Choinski | Sep 2013 | A1 |
20130245762 | Van Kampen et al. | Sep 2013 | A1 |
20130261662 | Mayer et al. | Oct 2013 | A1 |
20130274879 | Champagne et al. | Oct 2013 | A1 |
20130282058 | ElAttrache et al. | Oct 2013 | A1 |
20130325011 | Cleveland et al. | Dec 2013 | A1 |
20140025124 | Champagne et al. | Jan 2014 | A1 |
20140067063 | Bonutti | Mar 2014 | A1 |
20140257349 | Sudekum | Sep 2014 | A1 |
20140276846 | Mauldin | Sep 2014 | A1 |
20140336712 | Stmad et al. | Nov 2014 | A1 |
20150066060 | Bojarski | Mar 2015 | A1 |
20150094724 | Champagne et al. | Apr 2015 | A1 |
20150094777 | Champagne et al. | Apr 2015 | A1 |
20150173737 | Champagne et al. | Jun 2015 | A1 |
20150182325 | Champagne et al. | Jul 2015 | A1 |
20160030097 | Mildner | Feb 2016 | A1 |
20160256290 | Seavey et al. | Sep 2016 | A1 |
20160296263 | Champagne et al. | Oct 2016 | A1 |
20160296264 | Champagne et al. | Oct 2016 | A1 |
20160338748 | Champagne et al. | Nov 2016 | A1 |
20170027577 | Kubiak et al. | Feb 2017 | A1 |
20170035553 | Champagne et al. | Feb 2017 | A1 |
20170049167 | Champagne et al. | Feb 2017 | A1 |
20170189090 | Champagne et al. | Jul 2017 | A1 |
20170196609 | Champagne et al. | Jul 2017 | A1 |
20170325827 | Champagne et al. | Nov 2017 | A1 |
20180021124 | Champagne et al. | Jan 2018 | A1 |
20190336185 | Champagne et al. | Nov 2019 | A1 |
20200214750 | Champagne et al. | Jul 2020 | A1 |
Number | Date | Country |
---|---|---|
643131 | May 1984 | CH |
646858 | Dec 1984 | CH |
2713386 | Nov 1978 | DE |
102007003645 | Jul 2008 | DE |
202013101135 | Jun 2014 | DE |
0597223 | May 1994 | EP |
1378205 | Jan 2004 | EP |
2606843 | Jun 2013 | EP |
602013043888.9 | Sep 2018 | EP |
2007099 | May 1979 | GB |
2181356 | Apr 1987 | GB |
WO199733537 | Sep 1997 | WO |
WO2004093700 | Apr 2004 | WO |
WO2005092226 | Oct 2005 | WO |
WO2006105935 | Dec 2006 | WO |
WO2007081601 | Jul 2007 | WO |
WO2007109140 | Sep 2007 | WO |
WO2008063156 | May 2008 | WO |
WO2010151589 | Dec 2010 | WO |
2012050424 | Apr 2012 | WO |
WO2014011933 | Jan 2014 | WO |
2014089522 | Jun 2014 | WO |
2015050900 | Apr 2015 | WO |
WO2015050895 | Sep 2015 | WO |
WO2015050896 | Sep 2015 | WO |
WO2015050898 | Sep 2015 | WO |
WO2015050902 | Sep 2015 | WO |
2016186847 | Nov 2016 | WO |
Entry |
---|
PCT; International Search Report and Written Opinion dated Sep. 17, 2010 in Application No. PCT/US2009/046662. |
EP; Examination Report dated May 30, 2011 in Application No. EP 09774002.1. |
USPTO; Office Action dated Oct. 4, 2011 in U.S. Appl. No. 12/372,712. |
USPTO; Office Action dated Mar. 21, 2012 in U.S. Appl. No. 12/480,676. |
EP; Examination Report dated May 25, 2012 in Application No. EP 09774002.1. |
USPTO; Office Action dated May 29, 2012 in U.S. Appl. No. 12/372,712. |
USPTO; Office Action dated Sep. 18, 2012 in U.S. Appl. No. 12/480,676. |
USPTO; Office Action dated Mar. 22, 2013 in U.S. Appl. No. 12/372,712. |
USPTO; Notice of Allowance dated Jul. 30, 2013 in U.S. Appl. No. 12/372,712. |
PCT; International Search Report and Written Opinion dated Sep. 9, 2013 in Application No. PCT/US2013/050155. |
USPTO; Office Action dated Sep. 24, 2013 in U.S. Appl. No. 12/480,676. |
USPTO; Office Action dated Feb. 18, 2014 in U.S. Appl. No. 13/555,933. |
USPTO; Notice of Allowance dated Jun. 25, 2014 in U.S. Appl. No. 13/555,933. |
USPTO; Office Action dated Aug. 29, 2014 in U.S. Appl. No. 13/648,019. |
PCT; International Search Report and Written Opinion dated Dec. 10, 2014 in Application No. PCT/US2014/058463. |
PCT; International Search Report and Written Opinion dated Dec. 12, 2014 in Application No. PCT/US2014/058474. |
USPTO; Notice of Allowance dated Dec. 31, 2014 in U.S. Appl. No. 13/648,019. |
PCT; International Search Report and Written Opinion dated Jan. 20, 2015 in Application No. PCT/US2014/058448. |
PCT; International Search Report and Written Opinion dated Feb. 9, 2015 in Application No. PCT/US2014/058441. |
USPTO; Office Action dated Dec. 9, 2015 in U.S. Appl. No. 14/640,657. |
USPTO; Office Action dated Oct. 5, 2015 in U.S. Appl. No. 13/940,173. |
USPTO; Final Office Action dated May 23, 2016 in U.S. Appl. No. 13/940,173. |
USPTO; Notice of Allowance dated Jul. 1, 2016 in U.S. Appl. No. 13/940,173. |
USPTO; Notice of Allowance dated Sep. 1, 2016 in U.S. Appl. No. 14/640,657. |
USPTO; Non-Final Office Action dated Apr. 10, 2017 in U.S. Appl. No. 14/641,024. |
USPTO; Final Office Action dated Jun. 2, 2017 in U.S. Appl. No. 14/503,157. |
USPTO; Final Office Action dated Jun. 13, 2017 in U.S. Appl. No. 14/503,119. |
USPTO; Non-Final Office Action dated Nov. 4, 2016 in U.S. Appl. No. 14/503,119. |
USPTO; Non-Final Office Action dated Jan. 27, 2017 in U.S. Appl. No. 14/503,157. |
USPTO; Non-Final Office Action dated Feb. 21, 2018 in U.S. Appl. No. 15/151,252. |
USPTO; Non-Final Office Action dated Feb. 27, 2018 in U.S. Appl. No. 14/503,157. |
USPTO; Non-Final Office Action dated Mar. 5, 2018 in U.S. Appl. No. 14/993,972. |
USPTO; Non-Final Office Action dated Mar. 5, 2018 in U.S. Appl. No. 15/214,412. |
PCT; International Search Report and Written Opinion dated Sep. 30, 2014 in Application No. PCT/US2014/058472. |
PCT; International Search Report and Written Opinion dated May 4, 2016 in Application No. PCT/US2016/030850. |
USPTO; Non-Final Office Action dated Nov. 1, 2017 in U.S. Appl. No. 15/297,698. |
USPTO; Non-Final Office Action dated Nov. 28, 2017 in U.S. Appl. No. 15/189,845. |
USPTO; Non-Final Office Action dated Nov. 30, 2017 in U.S. Appl. No. 15/189,829. |
USPTO; Requirement for Restriction dated Nov. 30, 2017 in U.S. Appl. No. 15/214,412. |
USPTO; Non-Final Office Action dated Dec. 8, 2017 in U.S. Appl. No. 15/146,824. |
USPTO; Non-Final Office Action dated Dec. 15, 2017 in U.S. Appl. No. 14/984,145. |
EP; Examination Report dated Feb. 12, 2016 in Application No. EP 13742332.3. |
EP; 2nd Examination Report dated Oct. 11, 2016 in Application No. EP 13742332.3. |
EP; Notice of Allowance dated Apr. 12, 2018 in Application No. EP 13742332.3. |
USPTO; Notice of Allowance dated Jun. 15, 2018 in U.S. Appl. No. 15/189,845. |
USPTO; Final Office Action dated Jun. 26, 2018 in U.S. Appl. No. 14/984,145. |
USPTO; Notice of Allowance dated Jul. 11, 2018 in U.S. Appl. No. 15/189,845. |
USPTO; Final Office Action dated Jul. 20, 2018 in U.S. Appl. No. 14/993,972. |
USPTO; Final Office Action dated Aug. 8, 2018 in U.S. Appl. No. 15/214,412. |
USPTO; Final Office Action dated Aug. 13, 2018 in U.S. Appl. No. 15/151,252. |
USPTO; Notice of Allowance dated Sep. 18, 2018 in U.S. Appl. No. 15/151,252. |
USPTO; Final Office Action dated Oct. 17, 2018 in U.S. Appl. No. 15/146,824. |
Number | Date | Country | |
---|---|---|---|
20150094722 A1 | Apr 2015 | US |
Number | Date | Country | |
---|---|---|---|
61885748 | Oct 2013 | US |